Neurobiological Tech (NTII) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurobiological Tech (NTII)

NTII 0.0001000

0.0%

Mar 7 3:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: John McCarthy who wrote (1128)	1/17/2003 8:57:22 AM
From: lrb	Read Replies (1) of 1494

All, In yesterday's earnings conference call, FRX said that they had updated the NDA with the Aricept combo trial this week, and expect the FDA to decide on acceptability next month. With respect to diabetic neuropathy, they are currently conducting the second, confirmatory trial and expect to report top-line results by the middle of calendar 2003. CC: (memantine discussion begins at 6 min, 30 sec) biz.yahoo.com Larry

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next